The novel autophagy inhibitor ROC-325 augments the antileukemic activity of azacitidine

Leukemia. 2019 Dec;33(12):2971-2974. doi: 10.1038/s41375-019-0529-2. Epub 2019 Jul 29.

¹ Department of Medicine, The University of Arizona Comprehensive Cancer Center, Tucson, AZ, USA.
² Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA.
³ Jane Anne Nohl Division of Hematology and Center for the Study of Blood Diseases, University of Southern California Norris Comprehensive Cancer Center, Los Angeles, CA, USA.
⁴ Department of Medicine, The University of Arizona Comprehensive Cancer Center, Tucson, AZ, USA. jcarew@email.arizona.edu.

No abstract available

Publication types

1-(2-(2-((7-chloroquinolin-4-yl)amino)ethyl-methylamino)ethylamino)-4-methylthioxanthen-9-one
Antimetabolites, Antineoplastic
Hydroxychloroquine
Azacitidine